Paediatric Patient Safety and the Need for Aviation Black Box Thinking to Learn From and Prevent Medication Errors

Chi Huynh1,2, Ian C K Wong3,4, Jo Correa-West5

  • 1Academic Practice Unit, Pharmacy Department, Birmingham Children's Hospital NHS Foundation Trust, Birmingham, UK. c.huynh3@aston.ac.uk.

Paediatric Drugs
|February 11, 2017
PubMed

Insights

Despite improvements, fatal medication errors in children persist. Addressing human factors, reporting barriers, and enhancing education are crucial for preventing future pediatric medication errors.

Area of Science:

  • Pediatric Patient Safety
  • Medication Error Research
  • Healthcare Quality Improvement

Background:

  • Medication errors in children have been extensively studied since 1999.
  • While progress in pediatric medication safety is evident, serious and fatal errors continue to occur, as highlighted by media reports.

Purpose of the Study:

  • To critically examine the persistent problem of medication errors in children.
  • To provide recommendations for research, healthcare professional training, and cultural changes in managing medication errors.

Main Methods:

  • Analysis of factors contributing to medication errors in children.
  • Examination of barriers to learning from mistakes, including fear of litigation.
  • Assessment of educational needs for preventing medication errors.

Main Results:

  • Identified key areas for improvement: understanding who is involved, overcoming barriers to learning from errors, and enhancing educational strategies.
  • Highlighted the need for a cultural shift in reporting and addressing medication errors.

Conclusions:

  • Fatal medication errors in children remain a concern requiring multifaceted solutions.
  • Recommendations include applying aviation's 'black box' principles for incident investigation and promoting international data sharing.

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
47
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
405
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
343
Guidelines and Strategies for Safe Computer Charting01:18

Guidelines and Strategies for Safe Computer Charting

The guidelines and strategies provided by the American Nurses Association (ANA) and the Canadian Nurses Association (CNA) offer essential principles for ensuring safe and secure computer charting systems in healthcare settings. Let's break down each recommendation:
Maintain Confidentiality and Security:
3.0K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
304
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
625